Corneal Transplant Market By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2030
Global
Corneal Transplant Market - Overview
The Corneal
Transplant Market is projected to reach USD 680 million by 2030 at
7.10% CAGR during the forecast period 2022-2030.
The corneal transplant market is growing at a fast rate with the rise in
the number of eyesight-related corneal problems globally. The cornea is a vital
part of the human eye that is very susceptible to damage by an injury or by a
disease. The Corneal damage leads to blurred vision or even complete blindness
in some cases.
The global Corneal Transplant Market is growing pervasively over last
decade. Factors such as increasing prevalence injuries & diseases related
to the eye/ sight that fuel the transplants cases are fuelling the market
growth to an extent. Also the risk factors for the blindness & eye sight
disorders are creating the demand for the better Corneal Transplants and treatment methods in turn,
speed up the market growth.
Global
Corneal Transplant Market - Competitive
Analysis
The global Corneal Transplant market is a fragmented market with a
large number of players. Product development strategy has been curtailed by the
excellent efficiency and efficacy of drugs. However, the rise of drug
resistance has opened doors for new drug development and is an opportunity for
a new market leader. The rise of spurious and counterfeit medicines have
reduced the total market revenues and at the same time displaced standard drugs
off the market.
Global
Corneal Transplant Market - Segments
For an easy grasp and enhanced understanding, the report - Global Corneal
Transplant Market is segmented in to 4 Key dynamics;
·
By Surgery Types: Comprises
- Penetrating Keratoplasty, DSAEK (Descemet Stripping Automated
Endothelial Keratoplasty), Endothelial Keratoplasty, Corneal Graft, and Corneal
Limbal Stem Cell Transplant among others.
·
By Indications: Bullous
Keratopathy, Fungal Corneal Ulcer, Keratoconus, Corneal Stromal Dystrophies,
and Keratitis among others.
·
By End Users: Hospitals
& Eye clinics among others.
·
By Regions:
North America, Europe, APAC and Rest of the World.
Global
Corneal Transplant Market - Regional
Analysis
Globally,
Europe is the largest market for the Corneal Transplant. Factors such as the
availability of multiple treatment options, prevention strategy as well as
rising influence of organ donation programs, coupled with the increased
government emphasis on organ donation policies drive the regional growth of the
market. Moreover, increasing prevalence of diabetes in the region are providing
impetus to the market growth.
While North
America region stands as the second-largest market for Corneal Transplant. This
growth attributes to the increasing demand for corneal transplant surgery
coupled with the growing prevalence of eye diseases, and vision impairment
among people in the region drive the regional market growth. Moreover, growing
Centers for Disease Control and Prevention, coupled with the age-related eye
diseases such as age-related macular degeneration, cataract, diabetic
retinopathy, and glaucoma are leading causes of blindness and vision imparity
especially in the United States; such factors foster the regional market
growth.
On the other hand the developing regions markets particularly Asia Pacific will be the fastest growing market for Corneal Transplant. Risk factors for the eye diseases such as the ever-increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity provide impetus to the growth of the regional market. Attributing to the availability of qualitative eye care treatment and skilled medical professionals, India has become one of the international medical tourism destinations across the world. This, in turn fuels the growth of corneal transplant market in India resultantly, fostering the growth of the APAC market.
Industry/Innovations/Related
News:
·
March 10, 2018 – All India Institute of Medical Sciences
(AIIMS) announced that the eye bank housed in the AIIMS campus from last 50
years, have conducted around 17,000 corneal transplant surgeries till
date. Out of which 1,285 transplants were done in 2017. To commemorate the
occasion, the AIIMS had lined up various programmes.
·
March 22, 2018 – Researchers at UCL Institute of Ophthalmology
in collaboration with Moorfields Eye Hospital London published the study a new
genetic cause of corneal dystrophy that they have discovered. The research was
funded by the programme – ‘Fight for Sight’.
Competitive Landscape
The major global companies playing a
key role in the corneal transplant market are:
CryoLife, Inc. (U.S.), Exactech, Inc.
(U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation
(U.S.), Medtronic (U.S.), Organogenesis Inc. (U.S.)
Related Report-
https://www.linkedin.com/pulse/gene-panel-market-top-companies-business-growth-investment-gupta
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment